About this episode
The episode discusses the potential of MDMA as a treatment for veterans with PTSD, featuring insights from General Sir Nick Carter and Sky's science correspondent Thomas Moore.
The party drug ecstasy is usually associated with packed nightclubs and panicked politicians talking about the dangers involved in taking it. However, a former head of the UK’s armed forces believes the drug’s active ingredient, known as MDMA, could be key to treating veterans suffering from post-traumatic stress disorder. General Sir Nick Carter is now calling on the government to relax restrictions in order to reduce the crippling cost of clinical trials. What evidence is there to suggest this treatment could be effective and what’s been the reaction from the few former soldiers who have benefitted so far? Niall is joined by Sky’s science correspondent Thomas Moore. Warning: Contains references to drug taking, depression and suicide. Have you got a question for Niall? Email the show: why@sky.uk
People in this episode
Host: Niall
Guest: Thomas Moore
Topics covered
- MDMA
- PTSD
- veterans
- drug treatment
- clinical trials
- mental health
Keywords
- MDMA
- ecstasy
- PTSD
- veterans
- clinical trials
- mental health
- drug treatment
Mentioned in this episode
Organizations: Sky
More episodes of This Is Why
- Why Labour’s ‘Action Man’ Al Carns could challenge for No 10 · June 12, 2026 · 21 min
- Why the US’s Iran-fuelled inflation is trouble for Trump (and the UK) · June 11, 2026 · 15 min
- Why Belfast’s troubled past made violence inevitable · June 10, 2026 · 15 min
- Why the UK has fallen behind on drone warfare · June 9, 2026 · 16 min
- Why Trump and Netanyahu are split on Iran · June 8, 2026 · 17 min
- Why Beatrice and Eugenie living rent-free is a risk for the royals · June 5, 2026 · 18 min
Explore listener stats, chart rankings, contacts and more on the This Is Why podcast page.